Key Activities
Payer-focused, multi-stakeholder initiative to accelerate alignment of coverage with clinical evidence, advance reflex biomarker testing at diagnosis, advance the development of a standardized quality metric for biomarker testing, and educate payers on precision medicine. Includes Market Insights programs, Partnership Forums, formal recommendations submitted to NCCN guideline panels, research, demonstration projects, webinars, podcasts and consensus/best-practice recommendations for oncology biomarker testing in managed care.